Offer - Urjas Oil for just ₹ 1
Combiwave SF 50 Mcg/250 Mcg Inhaler is a prescription drug, available for use as Inhaler. The alternative uses of Combiwave SF 50 Mcg/250 Mcg Inhaler have also been explained below.
The correct dosage of Combiwave SF 50 Mcg/250 Mcg Inhaler depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
The side effects typically associated with Combiwave SF 50 Mcg/250 Mcg Inhaler include Shortness of Breath, Throat Irritation, Nosebleed. While these are the most often observed Combiwave SF 50 Mcg/250 Mcg Inhaler side effects, there are can be others also. These have been listed below. Usually, these side effects of Combiwave SF 50 Mcg/250 Mcg Inhaler go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Combiwave SF 50 Mcg/250 Mcg Inhaler's effect is Moderate during pregnancy and Mild for lactating mothers. In addition, Combiwave SF 50 Mcg/250 Mcg Inhaler's effects on the liver, heart and kidney are discussed below in the Combiwave SF 50 Mcg/250 Mcg Inhaler related warnings section.
The section on Combiwave SF 50 Mcg/250 Mcg Inhaler contraindications lists all such conditions.
Additionally, Combiwave SF 50 Mcg/250 Mcg Inhaler may also adversely react with other medicines. See below for a complete list.
You should also be aware that Combiwave SF 50 Mcg/250 Mcg Inhaler is safe while driving, and is addiction.
Combiwave SF 50 Mcg/250 Mcg Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| Adult |
|
| Geriatric |
|
Is the use of Combiwave SF 50 Mcg/250 Mcg Inhaler safe for pregnant women?
Combiwave SF can have harmful effects in pregnant women. If you experience any discomfort after using Combiwave SF, then discontinue the use and take your doctor's advice.
Is the use of Combiwave SF 50 Mcg/250 Mcg Inhaler safe during breastfeeding?
Combiwave SF may have very limited harmful effects for breastfeeding women.
What is the effect of Combiwave SF 50 Mcg/250 Mcg Inhaler on the Kidneys?
Combiwave SF is completely safe for kidneys.
What is the effect of Combiwave SF 50 Mcg/250 Mcg Inhaler on the Liver?
Combiwave SF may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Combiwave SF 50 Mcg/250 Mcg Inhaler on the Heart?
The heart can be affected by Combiwave SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Combiwave SF 50 Mcg/250 Mcg Inhaler unless your doctor advises you to do so -
Is this Combiwave SF 50 Mcg/250 Mcg Inhaler habit forming or addictive?
No, there is no any evidence that Combiwave SF 50 Mcg/250 Mcg Inhaler is addictive.
Interaction between Food and Combiwave SF 50 Mcg/250 Mcg Inhaler
There is no information on the effects of taking Combiwave SF 50 Mcg/250 Mcg Inhaler with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Combiwave SF 50 Mcg/250 Mcg Inhaler
It is difficult to say anything about the effect of Combiwave SF 50 Mcg/250 Mcg Inhaler and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359
